220 related articles for article (PubMed ID: 36213664)
1. Diagnosing interstitial lung disease by multidisciplinary discussion: A review.
Glenn LM; Troy LK; Corte TJ
Front Med (Lausanne); 2022; 9():1017501. PubMed ID: 36213664
[TBL] [Abstract][Full Text] [Related]
2. Essential Features of an Interstitial Lung Disease Multidisciplinary Meeting: An International Delphi Survey.
Teoh AKY; Holland AE; Morisset J; Flaherty KR; Wells AU; Walsh SLF; Glaspole I; Wuyts WA; Corte TJ;
Ann Am Thorac Soc; 2022 Jan; 19(1):66-73. PubMed ID: 34191689
[No Abstract] [Full Text] [Related]
3. Baseline Characteristics and Survival of an Australian Interstitial Pneumonia with Autoimmune Features Cohort.
Jee AS; Parker MJS; Bleasel JF; Troy LK; Lau EM; Jo HE; Teoh AKY; Adelstein S; Webster S; Corte TJ
Respiration; 2021; 100(9):853-864. PubMed ID: 33873185
[TBL] [Abstract][Full Text] [Related]
4. Impact of an interstitial lung disease service in the diagnosis and management of interstitial lung disease in Singapore.
Chai GT; Tan TC; Lee YS; Kaw GJ; Chuah KL; Lim YJ; Abisheganaden JA; Thong BY
Singapore Med J; 2020 Jun; 61(6):302-307. PubMed ID: 31317200
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the interstitial lung disease multidisciplinary meeting: a survey of expert centres.
Jo HE; Corte TJ; Moodley Y; Levin K; Westall G; Hopkins P; Chambers D; Glaspole I
BMC Pulm Med; 2016 Feb; 16():22. PubMed ID: 26831722
[TBL] [Abstract][Full Text] [Related]
6. Virtual communication is commonly used in Finnish interstitial lung disease multidisciplinary meetings.
Salonen J; Nurmi H; Hodgson U; Hasala H; Kilpeläinen M; Hollmen M; Purokivi M; Kaarteenaho R
Eur Clin Respir J; 2023; 10(1):2190210. PubMed ID: 36950471
[TBL] [Abstract][Full Text] [Related]
7. The interstitial lung disease multidisciplinary meeting: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia.
Prasad JD; Mahar A; Bleasel J; Ellis SJ; Chambers DC; Lake F; Hopkins PMA; Corte TJ; Allan H; Glaspole IN
Respirology; 2017 Oct; 22(7):1459-1472. PubMed ID: 28891101
[TBL] [Abstract][Full Text] [Related]
8. Unclassifiable interstitial lung disease: A review.
Skolnik K; Ryerson CJ
Respirology; 2016 Jan; 21(1):51-6. PubMed ID: 26059704
[TBL] [Abstract][Full Text] [Related]
9. Unclassifiable interstitial lung disease: from phenotyping to possible treatments.
Guler SA; Ryerson CJ
Curr Opin Pulm Med; 2018 Sep; 24(5):461-468. PubMed ID: 30004990
[TBL] [Abstract][Full Text] [Related]
10. Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature.
Ferri C; Manfredi A; Sebastiani M; Colaci M; Giuggioli D; Vacchi C; Della Casa G; Cerri S; Torricelli P; Luppi F
Autoimmun Rev; 2016 Jan; 15(1):61-70. PubMed ID: 26384526
[TBL] [Abstract][Full Text] [Related]
11. Real-life prevalence of progressive fibrosing interstitial lung diseases.
Gagliardi M; Berg DV; Heylen CE; Koenig S; Hoton D; Tamirou F; Pieters T; Ghaye B; Froidure A
Sci Rep; 2021 Dec; 11(1):23988. PubMed ID: 34907290
[TBL] [Abstract][Full Text] [Related]
12. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
Hyldgaard C
Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic interstitial pneumonias with connective tissue diseases features: A review.
Cottin V
Respirology; 2016 Feb; 21(2):245-58. PubMed ID: 26212251
[TBL] [Abstract][Full Text] [Related]
14. Cyclophosphamide for connective tissue disease-associated interstitial lung disease.
Barnes H; Holland AE; Westall GP; Goh NS; Glaspole IN
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD010908. PubMed ID: 29297205
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
[TBL] [Abstract][Full Text] [Related]
16. Current approach to connective tissue disease-associated interstitial lung disease.
Solomon JJ; Chartrand S; Fischer A
Curr Opin Pulm Med; 2014 Sep; 20(5):449-56. PubMed ID: 25022317
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive assessment of environmental exposures and the medical history guides multidisciplinary discussion in interstitial lung disease.
Dodia N; Amariei D; Kenaa B; Corwin D; Chelala L; Britt EJ; Sachdeva A; Luzina IG; Hasday JD; Shah NG; Atamas SP; Franks TJ; Burke AP; Hines SE; Galvin JR; Todd NW
Respir Med; 2021 Apr; 179():106333. PubMed ID: 33676119
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of the interstitial lung disease multidisciplinary service.
Jo HE; Glaspole IN; Levin KC; McCormack SR; Mahar AM; Cooper WA; Cameron R; Ellis SJ; Cottee AM; Webster SE; Troy LK; Torzillo PJ; Corte P; Symons KM; Taylor N; Corte TJ
Respirology; 2016 Nov; 21(8):1438-1444. PubMed ID: 27427515
[TBL] [Abstract][Full Text] [Related]
19. Unclassifiable interstitial lung diseases: Clinical characteristics and survival.
Hyldgaard C; Bendstrup E; Wells AU; Hilberg O
Respirology; 2017 Apr; 22(3):494-500. PubMed ID: 28297158
[TBL] [Abstract][Full Text] [Related]
20. The characterisation of interstitial lung disease multidisciplinary team meetings: a global study.
Richeldi L; Launders N; Martinez F; Walsh SLF; Myers J; Wang B; Jones M; Chisholm A; Flaherty KR
ERJ Open Res; 2019 Apr; 5(2):. PubMed ID: 30949489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
